Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QlearQuil Leverages Brand Into Allergy Space, Absorbs Existing ‘Quil’ Sinus Products

This article was originally published in The Tan Sheet

Executive Summary

P&G enters the OTC allergy category with QlearQuil products “for the occasional allergy sufferer.” But the firm also could be on the spot to prevent consumer confusion about indications for products in the broad selection with “Quil” in their brands.

You may also be interested in...



With PureZzzs, P&G Stretches ZzzQuil OTC Sleep Brand Into Supplement Space

P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.

P&G Stretches ZzzQuil Sleep Brand Into Supplement Space With PureZzzs

P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.

P&G Stretches ZzzQuil Sleep Brand Into Supplement Space With PureZzzs

P&G will launch Vicks ZzzQuil PureZzzs in late February as a drug-free, melatonin-based sleep aid, CFO Jon Moeller says. P&G hopes to reach $4.5bn in e-commerce sales in 2018, up from $3bn in 2017.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS107137

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel